Bellevue Asset Management, LLC Penumbra Inc Transaction History

Bellevue Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$235.0 - $310.7 $2,585 - $3,417	-11 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$175.6 - $291.43 $1,053 - $1,748	-6 Reduced 35.29%	11 $3,000
Q4 2020 Feb 11, 2021	SELL	$174.98 - $272.83 $349 - $545	-2 Reduced 10.53%	17 $4,000
Q3 2020 Nov 12, 2020	SELL	$185.27 - $238.73 $741 - $954	-4 Reduced 17.39%	19 $4,000
Q1 2020 May 13, 2020	BUY	$124.34 - $193.76 $1,243 - $1,937	10 Added 76.92%	23 $2,000
Q4 2019 Feb 13, 2020	BUY	$134.81 - $177.8 $1,752 - $2,311	13 New	13 $2,000

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.11B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellevue Asset Management, LLC with notifications on news.